Alternative approaches to IP regulation
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 16: | Line 16: | ||
Anti-commons in biomedical research [[http://0-find.galegroup.com.alpha2.latrobe.edu.au/itx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20606179&source=gale&srcprod=EAIM&userGroupName=latrobe&version=1.0 Anticommons]] | Anti-commons in biomedical research [[http://0-find.galegroup.com.alpha2.latrobe.edu.au/itx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20606179&source=gale&srcprod=EAIM&userGroupName=latrobe&version=1.0 Anticommons]] | ||
| + | |||
| + | Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]] | ||
Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] | Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] | ||
Revision as of 12:09, 9 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]
Brewster et al (2005) [Innovation Strategy Today]
ICRISAT Policy on IPRs [IP management]
Possible role for patent pooling in managing SARS [Patent Pooling]
Patent pools [Patent Pools]
Anti-commons in biomedical research [Anticommons]
Stiglitz on the Medical Prize Fund [BMJ]
Return to IP Resources page
